Anita Langerød's project group
TP53 and somatic genetics of breast cancer
Our research is focused on understanding the genomics of breast cancer, and in particular the role of TP53 and associated molecular networks. TP53 is a key regulator of many critical cellular processes and the gene is affected by mutation in breast cancer subtypes with poor prognosis. By integrating cancer genome profiling with single gene analysis in large series of patient samples, we aim to search for diagnostic, prognostic and predictive biomarkers of breast cancer.
Current projects and funding sources:
- Elucidating the TP53 network in breast cancer (Helse Sør-Øst)
- Breast Cancer Somatic Genetics Study (BASIS; EU FP7)
Contact information:
Department of Genetics, Institute for Cancer Research, Oslo University Hospital - Radiumhospitalet, Montebello, 0310 Oslo, Norway. Phone: +47 22 78 13 76, Fax: +47 22 78 13 95, Switchboard: +47 22 93 40 00. Email: anita.langerod@rr-research.no
Latest publictions
Anita Langerød
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma
Virchows Arch, 462 (2), 163-73
PubMed 23242172
The landscape of cancer genes and mutational processes in breast cancer
Nature, 486 (7403), 400-4
PubMed 22722201
Mutational processes molding the genomes of 21 breast cancers
Cell, 149 (5), 979-93
PubMed 22608084
More publications





Print this page
